P53 Protein Expression in Hepatoblastoma: An Immunohistochemical Investigation

References

• Lane D P. Mutation of the p53 protein: Common steps found in the majority of human cancers. Accomplishments in Cancer Research, J G Fortner, J E Rhodes. J.B. Lippincott, Philadelphia 1990; 252–66
   Google Scholar
• Steinmeyer K, Maacke H, Deppert W. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. Oncogene 1990; 5: 1691–9
   PubMed Web of Science ®Google Scholar
• Milner J. The role of p53 in normal control of cell proliferation. Curr Opin Cell Biol 1991; 3: 282–6
   PubMed Web of Science ®Google Scholar
• Hinds H P, Finlay C, Levine A J. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989; 63: 739–46
   PubMed Web of Science ®Google Scholar
• Bartek J, Iggo R, Gannon J, Lane D P. Genetic and immunocytochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893–9
   PubMed Web of Science ®Google Scholar
• Iggo R, Gatter K, Bartek J, Lane D, Harris A L. Increased expression of p53 oncogene in primary lung cancer. Lancet 1990; 335: 675–9
   PubMed Web of Science ®Google Scholar
• Lane D P, Benchimal S. p53: Oncogene or anti-oncogene. Gene Dev 1990; 4: 1–8
   PubMed Web of Science ®Google Scholar
• Levine A J, Momand J, Finlay C A. The p53 tumor suppressor gene. Nature 1991; 351: 453–6
   PubMed Web of Science ®Google Scholar
• Bartek J, Bartovka J, Vojtsek B, et al. Patterns of expression of the p53 tumor suppressor in human breast tissues in situ and in vitro. Int J Cancer 1990; 46: 839–44
   PubMed Web of Science ®Google Scholar
• Kafiri G, Thomas D M, Shepherd N A, Krausz T, Lane D P, Hall P A. p53 expression is common in malignant mesothelioma. Histopathology 1992; 21: 331–4
   PubMed Web of Science ®Google Scholar
• Lemoine N R, Hughes C M, Cowell J K. Aberrant expression of the tumor suppressor gene p53 is very frequent in Wilm's tumors. J Pathol 1992; 168: 237–42
   PubMed Web of Science ®Google Scholar
• Soini Y, Pääkkö P, Nuorva K, Kamel D, Lane D P, Vähäkangas K. Comparative analysis of p53 protein immunoreactivity in prostatic lung and breast carcinomas. Virchows Arch A Pathol Anat 1992; 421: 223–8
   Google Scholar
• Soini Y, Vähäkangas K, Nuorva K, Kamel D, Lane D P, Pääkkö P. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumors. J Pathol 1992; 168: 29–33
   PubMed Web of Science ®Google Scholar
• Sawan A, Randall B, Angus B, et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study. J Pathol 1992; 168: 23–8
   PubMed Web of Science ®Google Scholar
• Bressac B, Galvin K M, Liang T J, Isselbacher K J, Wands J R, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 1973–7
   PubMed Web of Science ®Google Scholar
• Hosono S, Lee C S, Chou M J, Yang C S, Shih C H. Molecular analysis of p53 alleles in primary hepatocellular carcinomas and cell lines. Oncogene 1991; 6: 237–43
   PubMed Web of Science ®Google Scholar
• Ishak K G, Glunz P R. Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer 1967; 20: 396–422
   PubMed Web of Science ®Google Scholar
• Ruck P, Harms D, Kaiserling E. Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation. Am J Surg Pathol 1990; 14: 847–55
   PubMed Web of Science ®Google Scholar
• Ruck P, Kaiserling E. Melanin-containing hepatoblastoma with endocrine differentiation. Cancer 1993; 72: 361–8
   PubMed Web of Science ®Google Scholar
• Hsu S-M, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80
   PubMed Web of Science ®Google Scholar
• Kasai M, Watanabe I. Histologic classification of liver-cell carcinoma in infancy and childhood and its clinical evaluation. A study of 70 cases collected in Japan. Cancer 1970; 25: 551–63
   PubMed Web of Science ®Google Scholar
• Gonzalez-Crussi F, Upton M P, Maurer H S. Hepatoblastoma: Attempt at characterization of histologic subtypes. Am J Surg Pathol 1982; 6: 599–612
   PubMed Web of Science ®Google Scholar
• Weinberg A G, Finegold M J. Primary hepatic tumors in childhood. Pathology of the Liver, M J Finegold. Saunders WB, Philadelphia 1986; 333–72
   Google Scholar
• Haas J E, Muczynski K A, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989; 64: 1082–9
   PubMed Web of Science ®Google Scholar
• Conran R M, Hitchcock C L, Waclawiw M A, Stocker J T, Ishak K G. Hepatoblastoma: The prognostic significance of histologic type. Pediatr Pathol 1992; 12: 167–83
   PubMed Web of Science ®Google Scholar
• Lehmann T A, Bennett W P, Metcalf R A, et al. p53 mutations, ras mutations and p53-heat shock protein complexes in human lung cell lines. Cancer Res 1991; 51: 4090–6
   PubMed Web of Science ®Google Scholar
• Vähäkangas K H, Samet J M, Metcalf R M, et al. Mutations of p53 and ras in radon-associated lung cancer from uranium miners. Lancet 1992; 339: 576–80
   PubMed Web of Science ®Google Scholar
• Abenoza P, Manivel J C, Wick M R, Hagen K, Dehner L P. Hepatoblastoma: An immunohistochemical and ultrastructural study. Hum Pathol 1987; 18: 1025–35
   PubMed Web of Science ®Google Scholar
• Dobashi Y, Sakamoto A, Sugimura H, et al. Overexpression of p53 is a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 1993; 17: 375–81
   PubMed Web of Science ®Google Scholar
• Catoretti G, Rilke F, Andreola S, D'Amato L, Delia D. p53 expression in breast cancer. Int J Cancer 1988; 41: 178–83
   PubMed Web of Science ®Google Scholar
• Fisher C J, Barnes D M, Gillet C E, et al. Immunohistochemical staining of mutant p53 proteins in carcinoma of the breast. J Pathol 1990; 161: 357A
   Web of Science ®Google Scholar
• Remvikos Y, Tominaga O, Hammel P, et al. Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer 1992; 66: 758–64
   PubMed Web of Science ®Google Scholar